Dr Eric Kusnadi
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
29 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Abstract SY24-02: Di-codon organization links tRNA modifications to cancer cell proteome composition
DOI: 10.1158/1538-7445.am2026-sy24-022026
Journal article
Abstract 427: PMR-116, a second-generation RNA polymerase I inhibitor displaying therapeutic efficacy in a broad spectrum of malignancies.
DOI: 10.1158/1538-7445.am2026-4272026
Journal article
Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
DOI: 10.1158/1538-7445.am2026-6012025
Journal article
77P PMR-116, a second generation ribosome biogenesis inhibitor, displays antitumour activity in a wide range of preclinical cancer models and on-target activity in a phase I trial
DOI: 10.1016/j.esmoop.2025.1054272024
Journal article
Second generation RNA Polymerase I inhibitor PMR-116 targets ribsomal RNA synthesis to potently treat a broad spectrum of malignancies
DOI: 10.1158/1538-8514.RNADRIVERS24-PR0042024
Conference Proceedings
Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
DOI: 10.1158/1538-8514.SYNTHLETH24-PR0072021
Research grants (other domestic)
Targeting Cellular Mechanisms That Regulate the Efficiency of Protein Synthesis to Improve Outcomes for Men With Metastatic Castrate Resistant Prostate Cancer
RECENT SCHOLARLY WORKS
2024
Conference Proceedings
Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
DOI: 10.1158/1538-8514.SYNTHLETH24-A0062024
Conference Proceedings
PMR-116, a second generation RNA Polymerase I inhibitor
DOI: 10.1158/1538-7445.AM2024-33262024
Journal article
Multi-omics approach reveals a SMAD4-deficiency signature, translational reprogramming and synthetic lethality in esophageal adenocarcinom
DOI: 10.1158/1538-7445.AM2024-55782023
Conference Proceedings
Loss of SMAD4 unleashes mTOR and increases dependency on cap-dependent translation in esophageal tumorigenesis
DOI: 10.1158/1535-7163.TARG-23-A176
RECENT PROJECTS
2021
Research grants (other domestic)
Targeting Cellular Mechanisms That Regulate the Efficiency of Protein Synthesis to Improve Outcomes for Men With Metastatic Castrate Resistant Prostate Cancer